DMR Logo.png
Pulmonary Arterial Hypertension Market Is Expected To Reach Revenue Of USD 13.2 Bn By 2033, At 5.6% CAGR: Dimension Market Research.
25 nov. 2024 09h35 HE | Dimension Market Research
New York, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Overview The Global Pulmonary Arterial Hypertension Market is projected to reach USD 8.1 billion in 2024 which is further anticipated to reach USD 13.2...
Logo.jpg
Pulmonary Arterial Hypertension Market To Reach USD 12.2 Billion By 2032 | DataHorizzon Research
10 mai 2024 05h00 HE | DataHorizzon Research
Fort Collins, Colorado, May 10, 2024 (GLOBE NEWSWIRE) -- The use of novel therapies and treatment strategies has encouraged significant developments for PAH. The global market for pulmonary...
factMR-logo.png
Pulmonary Arterial Hypertension (PAH) Market to Hit US$ 12.7 Billion by 2033: Fact.MR Report
20 août 2023 19h00 HE | FACT.MR
Rockville , Aug. 20, 2023 (GLOBE NEWSWIRE) -- Expanding at a CAGR of 5.4% from 2023 to 2033, the global pulmonary arterial hypertension market is forecasted to end up at a valuation of US$ 12.7...
Persistence Market Research
Pulmonary Arterial Hypertension Market Size Worth US$ 13.7 Bn and Grow at a CAGR of 6.2% From (2022-2032) - Persistence Market Research Report
24 janv. 2023 10h30 HE | Persistence Market Research
New York, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Pulmonary Arterial Hypertension Market revenues was estimated at US$ 7.1 Bn in 2021 and is anticipated to grow at a CAGR of 6.2% from 2022-2032,...
AMR Logo.png
Pulmonary Arterial Hypertension Market to Garner USD 12 Billion by 2031, Claims Allied Market Research
15 nov. 2022 19h00 HE | Allied Market Research
Portland, OR, Nov. 15, 2022 (GLOBE NEWSWIRE) -- As per the report published by Allied Market Research, the global pulmonary arterial hypertension market generated $7.2 billion in 2021, and is...
Transparency Market Research.jpg
Pulmonary Arterial Hypertension Market to reach a valuation of US$5.19 Bn by 2020, Says TMR
24 juil. 2018 07h27 HE | Transparency Market Research
Albany, NY, July 24, 2018 (GLOBE NEWSWIRE) -- According to TMR, the global pulmonary arterial hypertension therapeutics market is expected to reach a valuation of US$ 5.19 bn by the end of 2020. The...